Once again, the European Medicines Agency is taking action against a clinical research organization in India over faulty study data.
In the latest episode, the agency recommends suspending more than 300 drugs that are for sale or are being reviewed for use across the continent based on “misrepresentation of study data” conducted by Micro Therapeutic Research Labs, according to this statement.
About the Author Reprints
